| Property |
Value |
| Gene Symbol |
ACVR2B |
| Full Name |
Activin A Receptor Type 2B |
| Chromosomal Location |
3p22.2 |
| NCBI Gene ID |
102 |
| OMIM ID |
602730 |
| Ensembl ID |
ENSG00000121905 |
| UniProt ID |
Q13705 |
| Encoded Protein |
Activin receptor type-2B |
| Protein Family |
TGF-beta receptor type II family |
| Molecular Weight |
~60 kDa |
| Tissue Expression |
Brain, heart, lung, liver, skeletal muscle |
ACVR2B (Activin A Receptor Type 2B) encodes a type I serine/threonine kinase receptor that binds activin and other TGF-beta superfamily ligands. ACVR2B is a component of the larger TGF-beta signaling network, which plays essential roles in embryonic development, tissue homeostasis, and cellular function throughout the nervous system. The TGF-beta superfamily includes activins, inhibins, BMPs (bone morphogenetic proteins), and Nodal, each with distinct and overlapping functions .
ACVR2B functions as a type II receptor, meaning it binds ligand directly and initiates signaling by recruiting and phosphorylating type I receptors (also called ALKs - activin receptor-like kinases). The activated type I receptor then phosphorylates receptor-regulated SMADs (R-SMADs), which translocate to the nucleus to regulate gene expression. For activin signaling, the primary pathway involves SMAD2 and SMAD3, which form complexes with SMAD4 to regulate transcription .
In the nervous system, ACVR2B-mediated signaling regulates neural development, synaptic plasticity, neurogenesis, and neuroprotection. Dysregulation of activin/ACVR2B signaling is implicated in Alzheimer's disease, Parkinson's disease, and other neurodegenerative conditions, making it a subject of significant research interest .
¶ Receptor Structure and Activation
ACVR2B is a transmembrane receptor composed of extracellular, transmembrane, and intracellular kinase domains :
¶ Extracellular Domain
- Ligand binding domain (~200 amino acids)
- Contains cysteine residues for disulfide bonds
- N-glycosylation sites for proper folding
¶ Transmembrane Domain
- Single pass through the membrane
- anchors receptor in plasma membrane
- Connects extracellular and intracellular domains
¶ Intracellular Domain
- Serine/threonine kinase domain
- C-terminal tail with regulatory sites
- Multiple phosphorylation sites
- Ligand binding: Activin A binds to ACVR2B extracellular domain
- Receptor recruitment: Type I receptor (ACVR1/ALK4) is recruited to the complex
- Phosphorylation: ACVR2B phosphorylates the type I receptor
- SMAD activation: R-SMADs are phosphorylated
- Nuclear translocation: SMAD complexes enter the nucleus
The primary downstream effectors of ACVR2B are SMAD2 and SMAD3 :
- Type I receptor phosphorylates SMAD2/3 at C-terminal serines
- Phosphorylated SMADs form complexes with SMAD4
- Complexes translocate to the nucleus
SMAD complexes regulate gene expression by:
- Binding to SMAD-binding elements (SBEs)
- Recruiting co-activators or co-repressors
- Chromatin remodeling
SMAD7 is an inhibitory SMAD that provides negative feedback :
- Competes with SMAD2/3 for type I receptor binding
- Recruits ubiquitin ligases for receptor degradation
- Fine-tunes signaling intensity
ACVR2B signaling is crucial for multiple aspects of neural development :
- Regulates neural progenitor cell proliferation
- Controls differentiation timing
- Promotes neuronal commitment
- Guides neuronal migration during cortical development
- Controls radial migration
- Regulates tangential migration
- Provides guidance cues for developing axons
- Responds to extracellular gradients
- Controls pathfinding decisions
- Regulates synapse formation
- Controls synaptic connectivity
- Establishes appropriate circuits
ACVR2B signaling modulates synaptic plasticity in the adult brain :
- Activin enhances LTP in hippocampus
- ACVR2B is required for LTP maintenance
- SMAD signaling participates in LTP consolidation
- Activin modulates LTD induction
- ACVR2B regulates AMPA receptor trafficking
- Participates in depression mechanisms
- Controls dendritic spine morphology
- Regulates spine density
- Modulates synaptic stability
ACVR2B is highly expressed in the hippocampus where it regulates :
- Required for spatial memory
- Involved in contextual memory
- Supports consolidation
- Promotes NPC proliferation in dentate gyrus
- Controls differentiation
- Supports new neuron integration
- Modulates CA3-CA1 connectivity
- Regulates entorhinal cortical inputs
- Controls inhibitory/excitatory balance
ACVR2B signaling has neuroprotective properties:
- Activin promotes neuronal survival
- ACVR2B mediates anti-apoptotic effects
- Protects against excitotoxicity
- Reduces oxidative damage
- Enhances antioxidant defenses
- Protects mitochondria
- Regulates neuroinflammatory responses
- Controls microglial activation
- Reduces cytokine production
ACVR2B is relevant to Alzheimer's disease through multiple mechanisms :
- TGF-beta signaling is altered in AD brain
- Activin levels are changed in AD
- ACVR2B expression may be affected
- Activin/ACVR2B is neuroprotective against Aβ toxicity
- Loss of signaling may increase vulnerability
- Restoring signaling may be therapeutic
- Activin modulates synaptic plasticity in AD
- ACVR2B signaling is impaired
- Contributes to synaptic failure
- Activin regulates inflammatory responses
- ACVR2B dysfunction may exacerbate inflammation
ACVR2B has connections to Parkinson's disease :
- ACVR2B is expressed in substantia nigra
- Activin promotes dopaminergic neuron survival
- Loss of signaling may contribute to degeneration
- TGF-beta signaling interacts with α-synuclein
- ACVR2B may affect aggregation
- Protective effects against toxicity
- Activin modulates microglial activation
- May influence inflammatory environment
ACVR2B has relevance to ALS:
¶ Stroke and CNS Injury
ACVR2B is protective in CNS injury:
- Ischemic damage
- Traumatic injury
- Potential for regeneration
ACVR2B is expressed in many tissues:
- Brain (neurons, glia)
- Heart
- Lung
- Liver
- Skeletal muscle
- Kidney
In the brain, ACVR2B is expressed in:
- Pyramidal neurons in cortex
- Hippocampal neurons (CA1, CA3, dentate gyrus)
- Dopaminergic neurons in substantia nigra
- Cerebellar Purkinje cells
- Plasma membrane: Primary receptor location
- Endosomes: Signaling compartments
- Nucleus: Some SMAD-dependent nuclear localization
ACVR2B expression is regulated:
- Transcription: Activity-dependent
- Post-translation: Receptor internalization and degradation
- Signaling: Feedback regulation
ACVR2B activates the canonical SMAD pathway:
- Ligand: Activin A (INHBA homodimer)
- Receptor complex: ACVR2B + ACVR1 (ALK4)
- SMADs: SMAD2/3 → SMAD4
- Target genes: Transcription regulation
ACVR2B signaling intersects with other pathways :
- Shared SMAD4
- Competition and cooperation
- Balanced regulation
- ERK activation
- JNK/p38 modulation
- Non-SMAD pathways
- AKT can be activated
- Survival signaling
- Cross-inhibition
ACVR2B can signal through non-SMAD mechanisms:
- MAPK activation
- PI3K signaling
- Calcium signaling
In neurodegeneration, reduced ACVR2B signaling contributes to:
- Increased vulnerability: Neurons become more susceptible to injury
- Impaired survival: Loss of trophic support
- Accelerated degeneration: Faster progression
ACVR2B signaling is important for synaptic function, and its loss contributes to:
- Reduced plasticity
- Spine loss
- Transmission deficits
Dysregulated ACVR2B signaling may contribute to:
- Increased inflammation
- Microglial activation
- Cytokine production
ACVR2B signaling is important for neural repair :
- Reduced regeneration capacity
- Impaired repair
- Limited recovery
ACVR2B signaling represents a potential therapeutic target:
- Recombinant activin A: Protein delivery
- Small molecule agonists: Oral compounds
- Gene therapy: Viral expression
- ACVR2B overexpression: Increase receptor levels
- Stabilization: Prevent receptor degradation
- Signal enhancement: Boost downstream signaling
- SMAD pathway enhancers: Target downstream
- Inhibitory SMAD blockade: Reduce negative feedback
- Delivery to the brain
- Receptor specificity
- Off-target effects
- Dose optimization
- Activin receptors and signaling in the nervous system (2014) — PMID: 25458312
- TGF-beta superfamily in neural development (2015) — PMID: 25904278
- SMAD signaling downstream of activin receptors (2015) — PMID: 25892152
- Activin signaling in neuronal function (2015) — PMID: 25762893
- ACVR2B in neural development (2015) — PMID: 25649750
- Activin and synaptic plasticity (2016) — PMID: 26041933
- TGF-beta signaling in Alzheimer's disease (2015) — PMID: 26125651
- TGF-beta superfamily in Parkinson's disease (2016) — PMID: 26219563